Details for New Drug Application (NDA): 077843
✉ Email this page to a colleague
The generic ingredient in CABERGOLINE is cabergoline. There are twelve drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the cabergoline profile page.
Summary for 077843
Tradename: | CABERGOLINE |
Applicant: | Impax Labs Inc |
Ingredient: | cabergoline |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.5MG | ||||
Approval Date: | Jul 3, 2007 | TE: | RLD: | No |
Complete Access Available with Subscription